Insider Transactions in Q3 2023 at Arcus Biosciences, Inc. (RCUS)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
            Sep 22                          
            2023                          
           | Jennifer Jarrett Chief Operating Officer | 
              SELL
             
                Open market or private sale
             | Direct | 
              21,369
              -6.59%
           | 
              $406,011              
              $19.99 P/Share              
           | 
| 
            Sep 18                          
            2023                          
           | Jennifer Jarrett Chief Operating Officer | 
              SELL
             
                Sale (or disposition) back to the issuer
             | Direct | 
              12,506
              -3.72%
           | 
              $250,120              
              $20.4 P/Share              
           | 
| 
            Sep 18                          
            2023                          
           | Dimitry Sa Nuyten Chief Medical Officer | 
              SELL
             
                Sale (or disposition) back to the issuer
             | Direct | 
              3,708
              -4.8%
           | 
              $74,160              
              $20.4 P/Share              
           | 
| 
            Jul 28                          
            2023                          
           | Jennifer Jarrett Chief Operating Officer | 
              SELL
             
                Open market or private sale
             | Direct | 
              45,000
              -11.79%
           | 
              $900,000              
              $20.25 P/Share              
           | 
| 
            Jul 03                          
            2023                          
           | Alexander Azoy Chief Accounting Officer | 
              SELL
             
                Open market or private sale
             | Direct | 
              1,018
              -8.07%
           | 
              $20,360              
              $20.41 P/Share              
           |